Ocera
logo BDC

Ocera

Ocera is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel, first-in-class small molecule therapeutics for the treatment of acute (hospital-based) and chronic gastrointestinal (GI) motility disorders.

Investment year:  2001
Industry sector:  Biotechnology
Region:  Quebec
Website
Follow Ocera

Recent news

Tranzyme Pharma announces exercise of underwriters' over-allotment option and closing of $11.5 million registered direct offering of common stock

Learn More
v17.9.0.10395